We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKT icon
5951
CALL
Tanger
SKT
$4.52B
$110K ﹤0.01%
+7,500
New +$117K
YRD
5952
Yiren Digital
YRD
$110M
$110K ﹤0.01%
19,880
-40,621
-67% -$238K
TESS
5953
DELISTED
Tessco Technologies Inc
TESS
$110K ﹤0.01%
9,775
+2,853
+41% +$36.2K
PHAS
5954
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$110K ﹤0.01%
18,059
+5,139
+40% +$21.2K
EVFM
5955
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$110K ﹤0.01%
1,189
+445
+60% +$37.5K
GRVY
5956
GRAVITY
GRVY
$473M
$109K ﹤0.01%
2,903
+1,354
+87% +$48.5K
GCAP
5957
DELISTED
Gain Capital Holdings, Inc.
GCAP
$109K ﹤0.01%
27,647
+12,794
+86% +$55K
OQAL
5958
DELISTED
Invesco Russell 1000 Quality Factor ETF
OQAL
$109K ﹤0.01%
3,420
-376
-10% -$11.4K
ESPO icon
5959
VanEck Video Gaming and eSports ETF
ESPO
$258M
$107K ﹤0.01%
2,800
+1,518
+118% +$53.9K
FTHI icon
5960
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.45B
$107K ﹤0.01%
4,666
+3,928
+532% +$88.6K
GTES icon
5961
Gates Industrial Corporation Ltd.
GTES
$7.15B
$107K ﹤0.01%
7,765
+1,797
+30% +$20.5K
TXMD icon
5962
TherapeuticsMD
TXMD
$24M
$107K ﹤0.01%
879
-107
-11% -$15.4K
AGGP
5963
DELISTED
IQ Enhanced Core Plus Bond U.S. ETF
AGGP
$107K ﹤0.01%
5,386
-1,454
-21% -$28.6K
ALRS icon
5964
Alerus Financial
ALRS
$828M
$106K ﹤0.01%
+4,638
New +$102K
AMPY icon
5965
Amplify Energy
AMPY
$166M
$106K ﹤0.01%
16,110
+6,238
+63% +$40.2K
DBE icon
5966
Invesco DB Energy Fund
DBE
$85.3M
$106K ﹤0.01%
7,240
+947
+15% +$13.3K
DVY icon
5967
PUT
iShares Select Dividend ETF
DVY
$23.6B
$106K ﹤0.01%
+1,000
New +$103K
GHYG icon
5968
iShares US & Intl High Yield Corp Bond ETF
GHYG
$199M
$106K ﹤0.01%
2,117
+1,081
+104% +$53K
KRUS icon
5969
Kura Sushi USA
KRUS
$593M
$106K ﹤0.01%
4,161
+1,991
+92% +$43.9K
REMX icon
5970
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.26B
$106K ﹤0.01%
2,629
-855
-25% -$32.6K
AXU
5971
DELISTED
Alexco Resource Corp
AXU
$106K ﹤0.01%
45,583
-8,601
-16% -$15.8K
AXAS
5972
DELISTED
Abraxas Petroleum Corp
AXAS
$106K ﹤0.01%
15,064
+8,496
+129% +$54.8K
CROP
5973
DELISTED
IQ Global Agribusiness Small Cap ETF
CROP
$106K ﹤0.01%
3,242
+267
+9% +$8.64K
COMB icon
5974
GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF
COMB
$146M
$105K ﹤0.01%
4,316
+367
+9% +$8.78K
FXA icon
5975
Invesco CurrencyShares Australian Dollar Trust
FXA
$98M
$105K ﹤0.01%
1,490
-120
-7% -$8.21K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.